Research programme: inflammatory receptor regulators - Meyer

Drug Profile

Research programme: inflammatory receptor regulators - Meyer

Alternative Names: MP 8; TNF receptor releasing enzyme; TRRE

Latest Information Update: 07 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Meyer Pharmaceuticals
  • Class Biological peptides; Recombinant proteins
  • Mechanism of Action Immunosuppressants; Interleukin 6 inhibitors; Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Inflammation; Rheumatoid arthritis

Most Recent Events

  • 11 Jun 2003 MP8 is available for partnering
  • 11 Jun 2003 Preclinical trials in Inflammation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top